Stem cells combined with bone graft substitutes in skeletal tissue engineering

Area of Science:

• Regenerative Medicine
• Biomaterials Science
• Orthopedic Surgery

Background:

• Autografts offer the best outcomes for bone defects due to their cellular content.
• When autografts are unavailable, allografts and bone graft substitutes depend on host cells for osteogenic activity.

Purpose of the Study:

• To explore the potential of incorporating stem cells into bone graft substitutes to improve bone defect repair.
• To review different sources of stem cells and their applications in bone regeneration.

Main Methods:

• Review of literature on stem cell sources for bone grafting, including mesenchymal stem cells (MSCs) and embryonic stem cells (ESCs).
• Discussion of cell culture expansion and differentiation potential for osteogenesis.
• Examination of the use of synthetic scaffolds like hydroxyapatite and tricalcium phosphate.

Main Results:

• Mesenchymal stem cells (MSCs) from bone marrow are well-characterized for osteogenic differentiation.
• Combining bone marrow MSCs with synthetic scaffolds has yielded positive clinical results.
• Alternative MSC sources (adipose, muscle, umbilical cord) combined with scaffolds are promising but need more research.

Conclusions:

• Bone marrow MSCs with synthetic scaffolds represent a proven approach for bone defect repair.
• Further research is needed for MSCs from alternative sources and for pluripotent ESCs, focusing on purification, differentiation, delivery, and safety.
• Optimizing stem cell integration with scaffolds is crucial for enhancing bone regeneration.